Teva Pharma (TEVA) Offers $82/Share for Mylan (MYL)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/26/2024
- Futures climb as Alphabet, Microsoft results lift megacaps
- Microsoft fiscal Q3 results top estimates as AI revolution spurs cloud growth
- Alphabet stock surges 11% to record high on Q1 earnings beat, first-ever dividend
- Intel slides in afterhours trading as Q1 revenue misses, Q2 outlook falls short
- Oil prices on track to snap two-week losing streak
- Rubrik (RBRK) Prices Upsized 23.5M Share IPO at $32/sh
- Union Pacific beats profit estimates on stronger pricing, resumes share buyback
- IBM tumbles on soft Q1 revenue; announces HashiCorp $6.4bn acquisition
- Hertz Global (HTZ) misses earnings expectations as fleet costs weigh
- Teladoc (TDOC) Misses Q1 EPS by 3c, offers outlook
- Alphabet, Microsoft and Snap rise premarket; Intel, Hertz Global fall
- After-hours movers: Alphabet, Microsoft, Snap, Intel, and more
- Midday movers: Meta, IBM, Caterpillar fall; Chipotle rises
- After-hours movers: Meta, Ford, IBM, ServiceNow and more
- Midday movers: Tesla, Boeing rise; Uber, Old Dominion Freight fall
Stifel Downgrades Perrigo Co. (PRGO) to Hold
April 21, 2015 1:34 PM EDTStifel downgraded Perrigo Co. (NYSE: PRGO) from Buy to Hold.
For an analyst ratings summary and ratings history on Perrigo Co. click here. For more ratings news on Perrigo Co. click here.
Shares of Perrigo Co. closed at $198.08 yesterday.
... MoreBMO Capital Upgrades Mylan (MYL) to Market Perform
April 21, 2015 12:52 PM EDTBMO Capital upgraded Mylan (NASDAQ: MYL) from Underperform to Market Perform with a price target of $75.00 (from $41.00).
For an analyst ratings summary and ratings history on Mylan click here. For more ratings news on Mylan click here.
Shares of Mylan closed at $68.05 yesterday.
... MoreTeva Pharma (TEVA) Needs to Raise Mylan (MYL) Bid to $85-$88/Share, Leerink Partners Says
April 21, 2015 12:10 PM EDTLeerink Partners analyst Jason Gerberry weighed on Teva Pharma (NYSE: TEVA) after the company announced an unsolicited $82/share offer for Mylan (NASDAQ: MYL). The analyst said Teva will likely have to raise its bid to $85-$88 share and even that might not get it done. The analyst said while the deal makes sense, hostile deals carry a low success rate. Despite the comments, the firm... More
Teva (TEVA) May Approach Mylan (MYL) as Soon as Tuesday - Bloomberg
April 21, 2015 6:37 AM EDTTeva Pharma (NYSE: TEVA) is preparing an unsolicited offer for Mylan (NASDAQ: MYL) and could release a public bid for the company as soon as Tuesday, according to Bloomberg sources.
Teva Pharma (TEVA) Doesn't Need Mega Deal: Deutsche Bank (MYL)
April 20, 2015 9:10 AM EDTIt isn't all about size and near-term EPS accretion, said Deutsche Bank analyst Gregg Gilbert, speaking in regard to Teva Pharma (NYSE: TEVA) M&A. Comments follow rumors last week that suggested it was planning a bid for Mylan (NASDAQ: MYL). Mylan previously announced a deal to acquire Perrigo (NYSE:... More
Teva (TEVA) Said Considering Bid for Mylan (MYL)
April 17, 2015 2:21 PM EDT(Updated - April 17, 2015 2:26 PM EDT)
Mylan (Nasdaq: MYL) shares spiked and were paused Friday afternoon on reports Teva Pharma (NYSE: TEVA) is considering a bid for the company, according to Dow Jones... More
